The art of filling protein pockets efficiently with octahedral metal complexes.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

20 citing papers in PubMed.

1. Abiraterone Acetate Complexes with Biometals: Synthesis, Characterization in Solid and Solution, and the Nature of Chemical Bonding.Pharmaceutics · 2023
   Article
2. Targeting P21-Activated Kinase-1 for Metastatic Prostate Cancer.Cancers · 2023
   Review
3. Chemical and Physical Characterisation of Macroaggregated Human Serum Albumin: Strength and Specificity of Bonds withMolecules (Basel, Switzerland) · 2022
   Article
4. Label-Free Target Identification Reveals the Anticancer Mechanism of a Rhenium Isonitrile Complex.Frontiers in chemistry · 2022
   Article
5. Chemical and Physical Characterisation of Human Serum Albumin Nanocolloids: Kinetics, Strength and Specificity of Bonds withNanomaterials (Basel, Switzerland) · 2021
   Article
6. Metallohelices emulate the properties of short cationic α-helical peptides.Chemical science · 2021
   Review
7. Asymmetric construction of tetrahedral chiral zinc with high configurational stability and catalytic activity.Nature communications · 2020
   Article
8. P21-Activated Kinase 1: Emerging biological functions and potential therapeutic targets in Cancer.Theranostics · 2020
   Review
9. Solution structures and biophysical analysis of full-length group A PAKs reveal they are monomeric and auto-inhibited inThe Biochemical journal · 2019
   Article
10. Applications of Ruthenium Complex in Tumor Diagnosis and Therapy.Frontiers in pharmacology · 2018
    Review
11. The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials.Chemical Society reviews · 2017
    Review
12. Novel enantiopure cyclopentadienyl Ti(IV) oximato compounds as potential anticancer agents.Journal of inorganic biochemistry · 2016
    Article
13. Hydrogen bonding and anticancer properties of water-soluble chiralEuropean journal of inorganic chemistry · 2015
    Article
14. Rhenium Complexes with Red-Light-Induced Anticancer Activity.European journal of inorganic chemistry · 2014
    Article
15. An organometallic inhibitor for the human repair enzyme 7,8-dihydro-8-oxoguanosine triphosphatase.Angewandte Chemie (International ed. in English) · 2014
    Article
16. Non-ATP-Mimetic Organometallic Protein Kinase Inhibitor.ChemistryOpen · 2013
    Article
17. Mirror-image organometallic osmium arene iminopyridine halido complexes exhibit similar potent anticancer activity.Chemistry (Weinheim an der Bergstrasse, Germany) · 2013
    Article
18. FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated Schwannomas.The Journal of biological chemistry · 2013
    Article
19. Rhenium complexes with visible-light-induced anticancer activity.ChemMedChem · 2013
    Article
20. Bioactive cyclometalated phthalimides: design, synthesis and kinase inhibition.Dalton transactions (Cambridge, England : 2003) · 2012
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

6 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as